Tailored Intervention to Improve Medication Adherence in Patients With Hypertension
Pharmacist Intervention Programme in Secondary Care to Improve Medication Adherence in Patients With Hypertension
1 other identifier
interventional
532
1 country
1
Brief Summary
Patients with hypertension have an increased risk of stroke and myocardial infarction. However, poor adherence to treatment with antihypertensives and lipid-lowering agents occurs frequently within this patient group. The purpose of this study is to investigate whether a complex tailored intervention in a hospital setting will lead to increased medication adherence and fewer cardiovascular events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 4, 2012
CompletedFirst Posted
Study publicly available on registry
December 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedNovember 18, 2015
November 1, 2015
1.7 years
December 4, 2012
November 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of patients that are at least 80% adherent (Medication possession rate > 0.8) to antihypertensives and statins
One year from inclusion
Secondary Outcomes (3)
Non-persistence with antihypertensives and statins measured by percent of patients that are not supplied with medications for more than three continuous months
One year from inclusion
Reduction in systolic and diastolic blood pressure
One year from inclusion
Composite endpoint (stroke, myocardial infarction or cardiovascular death)
One year from inclusion
Study Arms (2)
Usual care
PLACEBO COMPARATORUsual care
Complex tailored intervention
EXPERIMENTALThe interventions consists of 3 elements: 1. Medication review with recommendations focused on antihypertensives and statins and adherence to guidelines and patient´s adherence to medications 2. Consultation with a pharmacist using motivational interviewing techniques 3. Follow-up telephone calls one month and six months after inclusion
Interventions
Eligibility Criteria
You may qualify if:
- Age: 18 years or older
- Patients receiving ambulatory treatment for hypertension in a hospital setting
- The patient or a carer usually dispenses the patient's medications
- Patient lives in the Southern Region of Denmark
- Written consent
You may not qualify if:
- Lives in a care home or institution
- Receive dose dispensed medicine from a pharmacy
- Medicine is dispensed by a nurse in the patient's home
- Correctional mental health patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Southern Denmarkcollaborator
Study Sites (1)
Odense University Hospital
Odense C, 5000, Denmark
Related Publications (2)
Hedegaard U, Kjeldsen LJ, Pottegard A, Henriksen JE, Lambrechtsen J, Hangaard J, Hallas J. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial. Am J Med. 2015 Dec;128(12):1351-61. doi: 10.1016/j.amjmed.2015.08.011. Epub 2015 Aug 21.
PMID: 26302142RESULTHedegaard U, Hallas J, Ravn-Nielsen LV, Kjeldsen LJ. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care. Res Social Adm Pharm. 2016 Mar-Apr;12(2):302-18. doi: 10.1016/j.sapharm.2015.05.006. Epub 2015 May 18.
PMID: 26088274RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student, MSc (pharm), Odense University Hospital
Study Record Dates
First Submitted
December 4, 2012
First Posted
December 6, 2012
Study Start
December 1, 2012
Primary Completion
August 1, 2014
Study Completion
September 1, 2014
Last Updated
November 18, 2015
Record last verified: 2015-11